Customizing Therapy for Esophageal Cancer: CROSS vs. FLOT
- PMID: 37833462
- DOI: 10.1245/s10434-023-14320-7
Customizing Therapy for Esophageal Cancer: CROSS vs. FLOT
Comment on
-
Long-Term Postsurgical Outcomes of Neoadjuvant Chemoradiation (CROSS) Versus Chemotherapy (FLOT) for Multimodal Treatment of Adenocarcinoma of the Esophagus and the Esophagogastric Junction.Ann Surg Oncol. 2023 Nov;30(12):7422-7433. doi: 10.1245/s10434-023-13643-9. Epub 2023 May 21. Ann Surg Oncol. 2023. PMID: 37210683 Free PMC article.
References
-
- van Hagen P, Hulshof MCCM, van Lanschot JJB, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366(22):2074–84. https://doi.org/10.1056/NEJMoa1112088 . - DOI - PubMed
-
- Al-Batran SE, Homann N, Pauligk C, et al. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial. Lancet. 2019;393(10184):1948–57. https://doi.org/10.1016/S0140-6736(18)32557-1 . - DOI - PubMed
-
- Reynolds JV, Preston SR, O’Neill B, et al. ICORG 10–14: NEOadjuvant trial in Adenocarcinoma of the oEsophagus and oesophagoGastric junction International Study (Neo-AEGIS). BMC Cancer. 2017;17(1):401. https://doi.org/10.1186/s12885-017-3386-2 . - DOI - PubMed - PMC
-
- Gebauer F, Plum PS, Damanakis A, et al. Long-term postsurgical outcomes of neoadjuvant chemoradiation (CROSS) versus chemotherapy (FLOT) for multimodal treatment of adenocarcinoma of the esophagus and the esophagogastric junction. Ann Surg Oncol. 2023. https://doi.org/10.1245/s10434-023-13643-9 . - DOI - PubMed - PMC
-
- Plum PS, Damanakis A, Buschmann L, et al. Short-term outcome of Ivor Lewis esophagectomy following neoadjuvant chemoradiation versus perioperative chemotherapy in patients with locally advanced adenocarcinoma of the esophagus and gastroesophageal junction: a propensity score-matched analysis. J Cancer Res Clin Oncol. 2022;148(5):1223–34. https://doi.org/10.1007/s00432-021-03720-5 . - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
